237 related articles for article (PubMed ID: 19585648)
61. Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells.
Yamamoto M; Hayashi N; Takehara T; Ueda K; Mita E; Tatsumi T; Sasaki Y; Kasahara A; Hori M
Hepatology; 1999 Jul; 30(1):300-7. PubMed ID: 10385671
[TBL] [Abstract][Full Text] [Related]
62. In silico analysis of functional single nucleotide polymorphisms in the human TRIM22 gene.
Kelly JN; Barr SD
PLoS One; 2014; 9(7):e101436. PubMed ID: 24983760
[TBL] [Abstract][Full Text] [Related]
63. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals.
Sawyer SL; Emerman M; Malik HS
PLoS Pathog; 2007 Dec; 3(12):e197. PubMed ID: 18159944
[TBL] [Abstract][Full Text] [Related]
64. [The fusion protein of cytoplasmic transduction peptide (CTP)-HBcAg18-27-Tapasin enhances specific immune response to hepatitis B virus and inhibits viral replication in transgenic mice].
Tang Y; Chen X; Zhou L; Zhuo M; Zang G; Tang Z; Yu Y
Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):24-9. PubMed ID: 24721239
[TBL] [Abstract][Full Text] [Related]
65. Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression.
Guarnieri M; Kim KH; Bang G; Li J; Zhou Y; Tang X; Wands J; Tong S
J Virol; 2006 Jan; 80(2):587-95. PubMed ID: 16378961
[TBL] [Abstract][Full Text] [Related]
66. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein.
Gordien E; Rosmorduc O; Peltekian C; Garreau F; Bréchot C; Kremsdorf D
J Virol; 2001 Mar; 75(6):2684-91. PubMed ID: 11222692
[TBL] [Abstract][Full Text] [Related]
67. Transcription and replication of a natural hepatitis B virus nucleocapsid promoter variant is regulated in vivo by peroxisome proliferators.
Raney AK; Kline EF; Tang H; McLachlan A
Virology; 2001 Oct; 289(2):239-51. PubMed ID: 11689047
[TBL] [Abstract][Full Text] [Related]
68. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
[TBL] [Abstract][Full Text] [Related]
69. GTPase activity is not essential for the interferon-inducible MxA protein to inhibit the replication of hepatitis B virus.
Yu Z; Wang Z; Chen J; Li H; Lin Z; Zhang F; Zhou Y; Hou J
Arch Virol; 2008; 153(9):1677-84. PubMed ID: 18668195
[TBL] [Abstract][Full Text] [Related]
70. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication.
Baumert TF; Rogers SA; Hasegawa K; Liang TJ
J Clin Invest; 1996 Nov; 98(10):2268-76. PubMed ID: 8941643
[TBL] [Abstract][Full Text] [Related]
71. Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5 alpha and 22.
Kajaste-Rudnitski A; Pultrone C; Marzetta F; Ghezzi S; Coradin T; Vicenzi E
Amino Acids; 2010 Jun; 39(1):1-9. PubMed ID: 19943174
[TBL] [Abstract][Full Text] [Related]
72. Elevated rate of fixation of endogenous retroviral elements in Haplorhini TRIM5 and TRIM22 genomic sequences: impact on transcriptional regulation.
Diehl WE; Johnson WE; Hunter E
PLoS One; 2013; 8(3):e58532. PubMed ID: 23516500
[TBL] [Abstract][Full Text] [Related]
73. Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1.
Forlani G; Tosi G; Turrini F; Poli G; Vicenzi E; Accolla RS
Front Immunol; 2017; 8():564. PubMed ID: 28555140
[TBL] [Abstract][Full Text] [Related]
74. TRIM22 suppresses Zika virus replication by targeting NS1 and NS3 for proteasomal degradation.
Zu S; Li C; Li L; Deng YQ; Chen X; Luo D; Ye Q; Huang YJ; Li XF; Zhang RR; Sun N; Zhang X; Aliyari SR; Nielsen-Saines K; Jung JU; Yang H; Qin CF; Cheng G
Cell Biosci; 2022 Aug; 12(1):139. PubMed ID: 36042495
[TBL] [Abstract][Full Text] [Related]
75. TRIM22 induces cellular senescence by targeting PHLPP2 in hepatocellular carcinoma.
Kang D; Hwang HJ; Baek Y; Sung JY; Kim K; Park HJ; Ko YG; Kim YN; Lee JS
Cell Death Dis; 2024 Jan; 15(1):26. PubMed ID: 38199981
[TBL] [Abstract][Full Text] [Related]
76. Suppression of hepatitis B viral gene expression by protein-tyrosine phosphatase PTPN3.
Hsu EC; Lin YC; Hung CS; Huang CJ; Lee MY; Yang SC; Ting LP
J Biomed Sci; 2007 Nov; 14(6):731-44. PubMed ID: 17588219
[TBL] [Abstract][Full Text] [Related]
77. Knockdown of Tripartite motif-containing 22 (TRIM22)relieved the apoptosis of lens epithelial cells by suppressing the expression of TNF receptor-associated factor 6 (TRAF6).
Meng K; Fang C
Bioengineered; 2021 Dec; 12(1):7213-7222. PubMed ID: 34558381
[TBL] [Abstract][Full Text] [Related]
78. TRIM22: A Diverse and Dynamic Antiviral Protein.
Hattlmann CJ; Kelly JN; Barr SD
Mol Biol Int; 2012; 2012():153415. PubMed ID: 22649727
[TBL] [Abstract][Full Text] [Related]
79. A Homokaryon Assay for Nucleocytoplasmic Shuttling Activity of HBV Core Protein.
Yang CC; Li HC; Shih C
Methods Mol Biol; 2017; 1540():53-58. PubMed ID: 27975307
[TBL] [Abstract][Full Text] [Related]
80. Aberrant KAT2A accumulations render TRIM22-low melanoma sensitive to Notch1 inhibitors via epigenetic reprogramming.
Gu X; Min W; Zeng Y; Fan N; Qian Q
J Transl Med; 2023 Jul; 21(1):443. PubMed ID: 37415153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
